4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
https://www.fool.com/investing/2024/04/14/nasdaq-bull-market-4-growth-stocks-regret-not-buy/?source=iedfolrf0000001
Apr 14, 2024 - Amazing deals can still be found by opportunistic investors, even with the Nasdaq Composite reaching new heights.
0
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
https://www.zacks.com/stock/news/2254638/astrazeneca-s-azn-fasenra-gets-fda-nod-for-asthma-in-kids?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254638
Apr 12, 2024 - The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
0
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
https://www.zacks.com/stock/news/2254409/pharma-stock-roundup-jnj-to-buy-shockwave-medical-other-pipeline-regulatory-news?cid=CS-ZC-FT-analyst_blog|stock_roundup-2254409
Apr 12, 2024 - J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.
0